Live feed16:39:44·508dINSIDERFilingvia QuantisnowAmendment: Director Galante Joseph C was granted 2,500 shares, increasing direct ownership by 4% to 60,856 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.CPIX· Cumberland Pharmaceuticals Inc.Health CareOriginal source